259 related articles for article (PubMed ID: 2024450)
1. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
[TBL] [Abstract][Full Text] [Related]
3. Light microscopical immunohistochemical study on parathyroid adenoma in primary hyperparathyroidism.
Oka T; Onoe K; Matsumiya K; Takaha M; Yoshioka T; Koide T; Sonoda T; Kimura M; Sakurai M
Urol Int; 1994; 52(3):121-5. PubMed ID: 7515533
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of GATA-3 in cytological identification of parathyroid tissues.
Takada N; Hirokawa M; Suzuki A; Higuchi M; Kuma S; Miyauchi A
Endocr J; 2016 Jul; 63(7):621-6. PubMed ID: 27097544
[TBL] [Abstract][Full Text] [Related]
5. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B.
Schmid KW; Morgan JM; Baumert M; Fischer-Colbrie R; Böcker W; Jasani B
Lab Invest; 1995 Jul; 73(1):90-5. PubMed ID: 7603045
[TBL] [Abstract][Full Text] [Related]
8. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
Hosokawa S
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
[TBL] [Abstract][Full Text] [Related]
9. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
[TBL] [Abstract][Full Text] [Related]
10. Storage and degradation of secretory proteins in adenomatous and secondary hyperplastic parathyroid cells. An immunoelectron microscope study.
Berger G; Berger F; Billard F; Danowski J; Vauzelle JL
Virchows Arch A Pathol Anat Histopathol; 1989; 415(4):305-16. PubMed ID: 2505443
[TBL] [Abstract][Full Text] [Related]
11. Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
Weber CJ; Russell J; Costanzo MK; Karp F; Benjamin M; Hardy MA; Feind CR
Surgery; 1992 Dec; 112(6):1089-94; discussion 1094-5. PubMed ID: 1455310
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 production and secretion by human parathyroids.
Safley SA; Villinger F; Jackson EH; Tucker-Burden C; Cohen C; Weber CJ
Clin Exp Immunol; 2004 Apr; 136(1):145-56. PubMed ID: 15030526
[TBL] [Abstract][Full Text] [Related]
14. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism.
Levine MA; Dempsey MA; Helman LJ; Ahn TG
J Clin Endocrinol Metab; 1990 Jun; 70(6):1668-73. PubMed ID: 2347900
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study.
Khan A; Tischler AS; Patwardhan NA; DeLellis RA
Endocr Pathol; 2003; 14(3):249-55. PubMed ID: 14586070
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions.
Saggiorato E; Bergero N; Volante M; Bacillo E; Rosas R; Gasparri G; Orlandi F; Papotti M
Am J Clin Pathol; 2006 Jul; 126(1):59-66. PubMed ID: 16753595
[TBL] [Abstract][Full Text] [Related]
18. [Effect of calcium and magnesium on parathyroid hormone release from human parathyroid tissue in vitro].
Wagner PK; Krause U; Rothmund M
Res Exp Med (Berl); 1982; 181(3):205-10. PubMed ID: 7163647
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism.
Oka T; Yoshioka T; Shrestha GR; Koide T; Sonoda T; Hosokawa S; Onoe K; Sakurai M
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):53-60. PubMed ID: 3131956
[TBL] [Abstract][Full Text] [Related]
20. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.
Juhlin C; Klareskog L; Nygren P; Ljunghall S; Gylfe E; Rastad J; Akerström G
Endocrinology; 1988 Jun; 122(6):2999-3001. PubMed ID: 2836180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
